Our interest in writing this article is to create a bridge between the scholarly and academic research on technological innovation and a private sector, for-profit business model that implements the ideas on innovation and entrepreneurship, primarily in metro regional economies. Radical...

This study examines whether and to what extent emerging-market multinational enterprises (EM MNEs) can use outward FDI in a developed market to capture knowledge spillovers so as to improve their technological capabilities at home. We refer to this as a “reverse spillover” effect on parent...

Is there knowledge adoption of innovations from emerging economies? We theorize that, to help overcome information asymmetry across countries, granting patents to technology in the emerging economy of China can serve as a signal of technology potential and market opportunity to enhance...

The present paper will look into the relationship between emerging markets and Europe in a twofold way. First, the paper will discuss the question from a European perspective, and investigate what impact emerging market patents may have on Europe. Second, the paper will briefly address the issue...

The implementation of patent law in the emerging market countries is having an impact on the international patent system. First, it is apparent that the principal emerging market economies are not strictly adhering to the patent regimen of the USA, Europe and Japan, but are instead adapting...

In their seminal 1972 article, "Property Rules, Liability Rules, and Inalienability: One View of the Cathedral," Guido Calabresi and A. Douglas Melamed proposed an analytic framework for comparing entitlements protected by property rules and liability rules. Their article has become one of the...

Professional mobility has profound importance for firm strategy, innovation, and productivity. Prior work on legal constraints on mobility has focused on non-compete covenants and patents. Here, we investigate the impact of the doctrine of inevitable disclosure in U.S. state-level trade secrets...

The future is now. According to some, we currently face the inevitability of a post-human world, a world where humans enhanced by science far exceed the capabilities of humans unaided by science. Genetic enhancement presents the most familiar way this future may occur. Science fiction films such...

On March 23, 2010, President Obama signed into law the Biologics Price Competition and Innovation Act of 2009 (‘BPCIA’) to create an abbreviated approval pathway for generic ‘biological products’ that are demonstrated to be highly similar (i.e., biosimilar) to or interchangeable with an...